Nosocomial pneumonia control programs: The most difficult questions

T. Pertseva, R. Bontsevich (Dnipropetrovs‘k, Ukraine; Belgorod, Russian Federation)

Source: Annual Congress 2012 - Prognostic indices in respiratory infections
Session: Prognostic indices in respiratory infections
Session type: Thematic Poster Session
Number: 2532
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
T. Pertseva, R. Bontsevich (Dnipropetrovs‘k, Ukraine; Belgorod, Russian Federation). Nosocomial pneumonia control programs: The most difficult questions. Eur Respir J 2012; 40: Suppl. 56, 2532

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Nosocomial pneumonia: treatment and prevention
Source: Annual Congress 2004 - PG22 - New perspectives in pneumonia treatment and prophylaxis
Year: 2004


Management of community-acquired pneumonia: new evidence-based algorithms.
Source: Virtual Congress 2021 – Emerging data for the management of respiratory tract infections
Year: 2021


From international guidelines to local guidelines for nosocomial pneumonia: what is missing?
Source: International Congress 2019 – Multidrug resistance in nosocomial pneumonia: burden, magnitude and solution
Year: 2019


VAP prevention: pharmacological strategies
Source: Eur Respir Mon 2011; 53: 74-82
Year: 2011


Prevention is better than cure: time to change the focus of community-acquired pneumonia management
Source: Eur Respir J 2015; 45: 1524-1525
Year: 2015


Treating nosocomial pneumonia: what's new
Source: ERJ Open Res, 4 (2) 00058-2018; 10.1183/23120541.00058-2018
Year: 2018



Hospital-acquired pneumonia: coverage and treatment adequacy of current guidelines
Source: Eur Respir J 2003 Dec 01;22(6):876-882
Year: 2003



The assessment of physicians' knowledge of community-acquired pneumonia basics: KNOCAP study
Source: International Congress 2019 – Medical education
Year: 2019


Improving outcomes from community-acquired pneumonia: we need to be more sophisticated about cause and effect
Source: Eur Respir J 2011; 39: 7-8
Year: 2012


Improving outcomes from community-acquired pneumonia: we need to be more sophisticated about cause and effect
Source: Eur Respir J 2012; 39: 7-8
Year: 2012


Nosocomial pneumonia in oncology
Source: Eur Respir J 2004; 24: Suppl. 48, 412s
Year: 2004

Outcomes characteristics in healthcare-associated pneumonia
Source: International Congress 2018 – Improving the outcomes of community-acquired pneumonia
Year: 2018




Nosocomial pneumonia: influence of smoking on the course of disease
Source: Annual Congress 2007 - Infectious lung and pleural diseases
Year: 2007


Infection control: a priority to stop the nosocomial spread of MDR-/XDR-TB
Source: Annual Congress 2012 - Infection control of respiratory pathogens
Year: 2012


Epidemiology, antimicrobial resistance and clinical outcomes in nursing home associated pneumonia compared to community acquired pneumonia
Source: Annual Congress 2013 –Antibiotics, resistance and vaccines
Year: 2013


Nosocomial pneumonia (non-ventilator-acquired)
Source: International Congress 2014 – PG16 Low respiratory tract infections: learning from real clinical cases
Year: 2014




Nosocomial pneumonia
Source: CME Online 2010
Year: 2005

International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia
Source: Guideline 2017
Year: 2017

International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia
Source: Eur Respir J, 50 (3) 1700582; 10.1183/13993003.00582-2017
Year: 2017